Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

DRUGS USED IN TREATMENT OF PATIENTS WITH PETIT MAL EPILEPSY

DRUGS USED IN TREATMENT OF PATIENTS WITH PETIT MAL EPILEPSY In a search for new drugs for patients with petit mal during the past several years, it became apparent to us that contradictory reports by various investigators were largely the result of lack of uniformity in presenting data and of differences in the nature of the case load itself. We felt that since the first aspect of the problem was largely statistical, this could greatly be improved by reporting results systematically and in some detail. The second difficulty—until there is more unanimity of opinion on diagnostic category—can, we believe, be minimized by the use of identical cases for all drugs evaluated. It was also clear that the effectiveness of new compounds could not be judged by comparison with each other or with standard drugs unless a standardized method of evaluation was used for all drugs tested. Since a solution to this problem is important, both to the epileptologist and the http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

DRUGS USED IN TREATMENT OF PATIENTS WITH PETIT MAL EPILEPSY

JAMA , Volume 157 (14) – Apr 2, 1955

Loading next page...
 
/lp/american-medical-association/drugs-used-in-treatment-of-patients-with-petit-mal-epilepsy-ShOuZO0tbe

References (3)

Publisher
American Medical Association
Copyright
Copyright © 1955 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1955.02950310020005
Publisher site
See Article on Publisher Site

Abstract

In a search for new drugs for patients with petit mal during the past several years, it became apparent to us that contradictory reports by various investigators were largely the result of lack of uniformity in presenting data and of differences in the nature of the case load itself. We felt that since the first aspect of the problem was largely statistical, this could greatly be improved by reporting results systematically and in some detail. The second difficulty—until there is more unanimity of opinion on diagnostic category—can, we believe, be minimized by the use of identical cases for all drugs evaluated. It was also clear that the effectiveness of new compounds could not be judged by comparison with each other or with standard drugs unless a standardized method of evaluation was used for all drugs tested. Since a solution to this problem is important, both to the epileptologist and the

Journal

JAMAAmerican Medical Association

Published: Apr 2, 1955

There are no references for this article.